Thimerosal
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Thimerosal
- DrugBank Accession Number
- DB11590
- Background
Thiomersal (INN), commonly known in the U.S. as thimerosal, is an organomercury compound. This compound is a well-established and widely used antiseptic and antifungal agent.
Developed in 1927, thimerosal has been and is still being used as a preservative in some cosmetics, topical pharmaceuticals, and biological drug products, which includes vaccines. There has been significant concern regarding its safety and toxicity in the last several decades. Although thimerosal is banned in several countries, it continues to be included as a preservative in some vaccines in the United States and many vaccines in the developing world 19.
- Type
- Small Molecule
- Groups
- Approved
- Structure
- Weight
- Average: 404.81
Monoisotopic: 405.992720501 - Chemical Formula
- C9H9HgNaO2S
- Synonyms
- [(o-carboxyphenyl)thio]ethylmercury sodium salt
- BTL-TML-COVID
- BTL-TML-HSV
- BTL-TML001
- ethyl(2-mercaptobenzoato-S)mercury sodium salt
- ethylmercurithiosalicylate sodium
- ethylmercurithiosalicylic acid sodium salt
- mercurothiolate
- o-(ethylmercurithio)benzoic acid sodium salt
- sodium ethylmercurithiosalicylate
- sodium merthiolate
- Thimerosal
- Thiomersal
- Thiomersalate
- Thiomersalum
- Tiomersal
Pharmacology
- Indication
Used as preservative in some cosmetics, topical pharmaceuticals, and biological drug products, which includes vaccines 5,6,7.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Thimerosal is an organomercurial compound and derivative of thiosalicyclic acid with antibacterial and antifungal properties 6. Thimerosal, which consists of approximately 50% mercury by weight, has been one of the most widely used preservatives in vaccines. It is metabolized/degraded to ethylmercury and thiosalicylate. Ethylmercury is an organomercurial that must be carefully distinguished from methylmercury, a closely related substance that has been the focus of many studies. Methylmercury is the type of mercury found in various species of fish 22. Experimental data demonstrates that the toxicokinetics of thimerosal (ethylmercury) is vastly different from that of methyl-mercury. Thus, methyl-mercury is not a suitable reference for assessing the risk from exposure to thimerosal-derived mercury 25.
Prior to the recent initiative to reduce or eliminate thimerosal from childhood vaccines, the maximum cumulative exposure to mercury via routine childhood vaccinations during the first 6 months of life was 187.5 micrograms. In the most recently formulated vaccines, the maximum cumulative exposure during the first 6 months of life should now be less than 3 micrograms of mercury. Currently, thimerosal may still be used in the early stages of manufacturing of certain childhood vaccines, however, only a trace remains after a chemical purification process. Note that the dose above is indicated for children 1-6 months of age is applicable only in the United States, and other countries may have varying indications 21.
- Mechanism of action
Although its mechanism of action is not fully understood, thimerosal inhibits sulfhydryl-containing active site of various enzymes and binds to sulfhydryl compounds, including glutathione, cysteine, and sulfhydryl groups of proteins. In addition, thimerosal activates the InsP3 calcium channel on the endoplasmic reticular membrane, thereby triggering the release of intracellular calcium resulting in a calcium-induced calcium-influx of extracellular calcium. Therefore, thimerosal may induce or inhibit various cellular functions that are dependent on the signaling of calcium 8.
Ethylmercury is metabolized to inorganic mercury more rapidly than methylmercury. This difference in metabolism may account for kidney pathology that can result from toxic quantities. Also, whereas the increase in oxidative stress and induction of apoptosis observed in vitro with large doses (405 μg/L to 101 mg/L) of thimerosal may explain its damaging neurological effects. The effects of low-dose ethylmercury are not completely understood to date. It is known, however, that the shorter half-life of ethylmercury (the metabolite of thimerosal) allows for very limited opportunities of ethylmercury derived from thimerosal in vaccines 8.
Ethylmercury is a lipophilic cation that is capable of crossing the blood-brain barrier. The octanol/water partition coefficients of methyl and ethylmercury are 1.4 to 1.8, at intracellular pH and [Cl−], therefore, both organomercury compounds will primarily exist as intracellular lipophilic cations. It has been demonstrated that lipophilic cations accumulate inside mitochondria, in a Nernstian fashion, driven by the steady state membrane potential. As the typical mitochondrial membrane potential of astrocytes and neurons is between 140–170 mV, one would expect the concentration of these organomercury compounds within mitochondria to be approximately 1000 times greater than the cytosolic concentration 23.
Target Actions Organism UMethionine synthase antagonistHumans UCystine/glutamate transporter antagonistHumans USodium/potassium-transporting ATPase subunit gamma antagonistHumans - Absorption
Less than 0.01% of an ingested dose is absorbed from the GI tract (rat study) 21.
- Volume of distribution
266 L in one study 12
- Protein binding
95 to 99% (depending on animal species and experimental conditions) of the mercury in plasma is bound to albumin (along with other plasma proteins). As significant proportion of albumin is filtered at the glomerulus 26.
- Metabolism
Ethylmercury (etHg) is derived from the metabolism of thimerosal (o-carboxyphenyl-thio-ethyl-sodium salt), which is the most widely used form of organic mercury 1.
- Route of elimination
Gastrointestinal tract 9.
- Half-life
A study was done to study the pharmacokinetics of Thimerosal in mice. Estimated half-lives (in days) were 8.8 for blood, 10.7 for brain, 7.8 for heart, 7.7 for liver and 45.2 for kidney.19
The the half-life of ethylmercury is 3–7 days in infants, with the half-life of intramuscular ethylmercury from thimerosal being 2.9-4.1 days.28 The half-life of ethylmercury in the blood also did not vary significant between age groups of infants, alongside the results that blood mercury levels before vaccination being similar in 2 month old and 6 month old infants suggests ethylmercury does not accumulate in the blood.4
- Clearance
The high concentrations of mercury identified in stool samples suggest that ethylmercury may be eliminated through the gastrointestinal tract 9.
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Ld50 Oral: 75 mg/kg (mouse), 91 mg/kg (mouse) 27
Although methylmercury (meHg) is considered a hazardous substance that is to be avoided even at small levels when consumed in foods such as seafood and rice (in Asia), the World Health Organization considers small doses of thimerosal safe regardless of multiple/repetitive exposures to vaccines that are predominantly taken during pregnancy or infancy 19,20,23.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareLatanoprost Thimerosal can cause a decrease in the absorption of Latanoprost resulting in a reduced serum concentration and potentially a decrease in efficacy. - Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Active Moieties
Name Kind UNII CAS InChI Key Ethylmercurithiosalicylic acid unknown 4071N4J64W 148-61-8 HXQVQGWHFRNKMS-UHFFFAOYSA-M - International/Other Brands
- Mersol
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image T.R.U.E. Test Thin-Layer Rapid Use Patch Test Thimerosal (6 ug/48h) + 2,2'-Dibenzothiazyl disulfide (20 ug/48h) + 2-mercaptobenzothiazole (61 ug/48h) + 4-(Isopropylamino)diphenylamine (10 ug/48h) + Bacitracin (486 ug/48h) + Balsam of Peru (648 ug/48h) + Benzocaine (378 ug/48h) + Benzylparaben (162 ug/48h) + Bisphenol A diglycidyl ether (32 ug/48h) + Bromothalonil (4 ug/48h) + Bronopol (203 ug/48h) + Budesonide (0.8 ug/48h) + Butylparaben (162 ug/48h) + Chlorquinaldol (77 ug/48h) + Cinchocaine hydrochloride (66 ug/48h) + Cinnamaldehyde (41 ug/48h) + Cinnamyl alcohol (63 ug/48h) + Clioquinol (77 ug/48h) + Cobalt chloride hexahydrate (4 ug/48h) + Diazolidinylurea (446 ug/48h) + Potassium dichromate (15.7 ug/48h) + Dipentamethylenethiuram disulfide (5.5 ug/48h) + Diphenylguanidine (68 ug/48h) + Disperse Blue 106 (41 ug/48h) + Disulfiram (5.5 ug/48h) + Ditiocarb zinc (68 ug/48h) + Ethyl hydroxybenzoate (162 ug/48h) + Ethylenediamine (18 ug/48h) + Eugenol (41 ug/48h) + Evernia prunastri (81 ug/48h) + Formaldehyde (146 ug/48h) + Geraniol (81 ug/48h) + Hydrocortisone butyrate (16 ug/48h) + Hydroxycitronellal (63 ug/48h) + Imidurea (486 ug/48h) + Isoeugenol (17 ug/48h) + Lanolin alcohols (810 ug/48h) + Methylchloroisothiazolinone (3 ug/48h) + Methylparaben (162 ug/48h) + Morpholinylmercaptobenzothiazole (20 ug/48h) + N,N'-diphenyl-1,4-phenylenediamine (25 ug/48h) + N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine (25 ug/48h) + Neomycin sulfate (486 ug/48h) + Nickel sulfate hexahydrate (36 ug/48h) + Parthenolide (2 ug/48h) + Propylparaben (162 ug/48h) + Quaternium-15 (81 ug/48h) + Rosin (972 ug/48h) + Sodium aurotiosulfate (23 ug/48h) + Tetracaine hydrochloride (66 ug/48h) + Tetramethylthiuram monosulfide (5.5 ug/48h) + Thiohexam (20 ug/48h) + Thiram (5.5 ug/48h) + Tixocortol pivalate (2 ug/48h) + Zinc dibutyldithiocarbamate (68 ug/48h) + alpha-Amyl cinnamaldehyde (17 ug/48h) + p-Phenylenediamine (65 ug/48h) + p-tert-Butylphenol-formaldehyde resin (low molecular weight) (36 ug/48h) Kit Cutaneous SmartPractice Denmark ApS 2012-03-01 Not applicable US Welders Eye Ease Thimerosal (4.07 %) + Boric acid (2.31 %) + Butacaine sulfate (.14 %) + Camphor (2 %) + Witch hazel (6.39 %) Liquid Ophthalmic Canadian Custom Packaging Company 1965-12-31 2006-03-21 Canada
Categories
- ATC Codes
- D08AK06 — Thiomersal
- Drug Categories
- Alkylmercury Compounds
- Antiseptics and Disinfectants
- Cell-mediated Immunity
- Compounds used in a research, industrial, or household setting
- Dermatologicals
- Ethylmercury Compounds
- Increased Histamine Release
- Mercurial Products
- Organomercury Compounds
- Organometallic Compounds
- Pharmaceutic Aids
- Pharmaceutical Preparations
- Preservatives, Pharmaceutical
- Standardized Chemical Allergen
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as o-sulfanylbenzoic acids. These are benzoic acids which bear a sulfanyl group (R-SH) attached to the benzene ring at positions 1 and 2, respectively.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Benzoic acids and derivatives
- Direct Parent
- O-sulfanylbenzoic acids
- Alternative Parents
- Benzoic acids / Benzoyl derivatives / Monocarboxylic acids and derivatives / Carboxylic acids / Transition metal alkyls / Organosulfur compounds / Organooxygen compounds / Organic salts / Organic oxides / Hydrocarbon derivatives show 1 more
- Substituents
- Alkyl mercury compound / Aromatic homomonocyclic compound / Benzoic acid / Benzoyl / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Monocarboxylic acid or derivatives / O-sulfanylbenzoic acid / Organic oxide show 8 more
- Molecular Framework
- Not Available
- External Descriptors
- alkylmercury compound (CHEBI:9546)
- Affected organisms
- Humans
Chemical Identifiers
- UNII
- 2225PI3MOV
- CAS number
- 54-64-8
- InChI Key
- RTKIYNMVFMVABJ-UHFFFAOYSA-L
- InChI
- InChI=1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2
- IUPAC Name
- sodium [(2-carboxylatophenyl)sulfanyl](ethyl)mercury
- SMILES
- [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O
References
- General References
- Dorea JG, Farina M, Rocha JB: Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury. J Appl Toxicol. 2013 Aug;33(8):700-11. doi: 10.1002/jat.2855. Epub 2013 Feb 11. [Article]
- Hussain S, Atkinson A, Thompson SJ, Khan AT: Accumulation of mercury and its effect on antioxidant enzymes in brain, liver, and kidneys of mice. J Environ Sci Health B. 1999 Jul;34(4):645-60. doi: 10.1080/03601239909373219. [Article]
- Geier DA, Sykes LK, Geier MR: A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J Toxicol Environ Health B Crit Rev. 2007 Dec;10(8):575-96. doi: 10.1080/10937400701389875. [Article]
- Hurley AM, Tadrous M, Miller ES: Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies. J Pediatr Pharmacol Ther. 2010 Jul;15(3):173-81. [Article]
- Thimerosal and Vaccines [Link]
- Thimerosal, Pubchem [Link]
- Questions about Vaccines [Link]
- 54-64-8(Thimerosal) Product Description [Link]
- Thimerosal-Containing Vaccines and Autism: A Review of Recent Epidemiologic Studies [Link]
- Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems [Link]
- Thimerosal [54-64-8] [Link]
- Toxicokinetics of Mercury after Long-Term Repeated Exposure to Thimerosal-Containing Vaccine [Link]
- https://www.researchgate.net/publication/51732698_Administration_of_Thimerosal_to_Infant_Rats_Increases_Overflow_of_Glutamate_and_Aspartate_in_the_Prefrontal_Cortex_Protective_Role_of_Dehydroepiandrosterone_Sulfate [Link]
- Thimerosal, an overview [Link]
- Thimerosal in Flu Vaccine [Link]
- Thimerosal and Animal Brains: New Data for Assessing Human Ethylmercury Risk [Link]
- Thimerosal: Clinical, epidemiologic and biochemical studies [Link]
- The Thimerosal Controversy [Link]
- A systematic study of the disposition and metabolism of mercury species in mice after exposure to low levels of thimerosal (ethylmercury) [Link]
- Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury [Link]
- Mercury [Link]
- The toxicology of Mercury [Link]
- The Toxicology of Mercury [Link]
- Sigma Aldrich Thimerosal [Link]
- Identification and distribution of mercury species in rat tissues following administration of Thimerosal or methylmercury [Link]
- Molecular Interactions with Mercury in the Kidney [Link]
- Material Safety Data Sheet Thimerosal MSDS [Link]
- World Health Organization: Thiomersal vaccines [Link]
- External Links
- KEGG Drug
- D00864
- PubChem Compound
- 16684434
- PubChem Substance
- 347827997
- ChemSpider
- 5697
- BindingDB
- 512713
- 10472
- ChEBI
- 9546
- ChEMBL
- CHEMBL508338
- Wikipedia
- Thiomersal
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Prevention Hepatitis E 1 somestatus stop reason just information to hide 3 Completed Prevention Flu caused by Influenza 4 somestatus stop reason just information to hide 3 Completed Prevention Viral Hepatitis B 2 somestatus stop reason just information to hide 2 Completed Prevention Flu caused by Influenza 1 somestatus stop reason just information to hide 2 Completed Treatment Coronavirus Disease 2019 (COVID‑19) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Topical 0.1 g Kit Cutaneous Tincture Topical Liquid Ophthalmic - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) -38.87 http://scorecard.goodguide.com/chemical-profiles/html/mercury.html boiling point (°C) 357.3 https://www.canada.ca/en/environment-climate-change/services/pollutants/mercury-environment/about/chemical-properties.html water solubility 1 g/mL https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/1/t5125pis.pdf - Predicted Properties
Property Value Source Water Solubility 6.17 mg/mL ALOGPS logP 2.58 ALOGPS logP 2.35 Chemaxon logS -1.8 ALOGPS pKa (Strongest Acidic) 3.62 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 40.13 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 59.82 m3·mol-1 Chemaxon Polarizability 20.6 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 128.5037668 predictedDarkChem Lite v0.1.0 [M-H]- 128.5250668 predictedDarkChem Lite v0.1.0
Targets
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Antagonist
- General Function
- Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol (PubMed:16769880, PubMed:17288554, PubMed:27771510). MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate (PubMed:16769880, PubMed:17288554, PubMed:27771510). The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine (PubMed:16769880, PubMed:27771510)
- Specific Function
- cobalamin binding
- Gene Name
- MTR
- Uniprot ID
- Q99707
- Uniprot Name
- Methionine synthase
- Molecular Weight
- 140525.91 Da
References
- Sigma Aldrich Thimerosal [Link]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Antagonist
- General Function
- Heterodimer with SLC3A2, that functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane (PubMed:11133847, PubMed:11417227, PubMed:14722095, PubMed:15151999, PubMed:34880232, PubMed:35245456, PubMed:35352032). Provides L-cystine for the maintenance of the redox balance between extracellular L-cystine and L-cysteine and for the maintenance of the intracellular levels of glutathione that is essential for cells protection from oxidative stress (By similarity). The transport is sodium-independent, electroneutral with a stoichiometry of 1:1, and is drove by the high intracellular concentration of L-glutamate and the intracellular reduction of L-cystine (PubMed:11133847, PubMed:11417227). In addition, mediates the import of L-kynurenine leading to anti-ferroptotic signaling propagation required to maintain L-cystine and glutathione homeostasis (PubMed:35245456). Moreover, mediates N-acetyl-L-cysteine uptake into the placenta leading to subsequently down-regulation of pathways associated with oxidative stress, inflammation and apoptosis (PubMed:34120018). In vitro can also transport L-aspartate (PubMed:11417227). May participate in astrocyte and meningeal cell proliferation during development and can provide neuroprotection by promoting glutathione synthesis and delivery from non-neuronal cells such as astrocytes and meningeal cells to immature neurons (By similarity). Controls the production of pheomelanin pigment directly (By similarity)
- Specific Function
- cystine
- Gene Name
- SLC7A11
- Uniprot ID
- Q9UPY5
- Uniprot Name
- Cystine/glutamate transporter
- Molecular Weight
- 55422.44 Da
References
- Sigma Aldrich Thimerosal [Link]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Antagonist
- General Function
- May be involved in forming the receptor site for cardiac glycoside binding or may modulate the transport function of the sodium ATPase
- Specific Function
- ATPase activator activity
- Gene Name
- FXYD2
- Uniprot ID
- P54710
- Uniprot Name
- Sodium/potassium-transporting ATPase subunit gamma
- Molecular Weight
- 7283.265 Da
References
- Sigma Aldrich Thimerosal [Link]
Enzymes
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Inducer
- General Function
- Maintains high levels of reduced glutathione in the cytosol
- Specific Function
- electron transfer activity
- Gene Name
- GSR
- Uniprot ID
- P00390
- Uniprot Name
- Glutathione reductase, mitochondrial
- Molecular Weight
- 56256.565 Da
References
- Hussain S, Atkinson A, Thompson SJ, Khan AT: Accumulation of mercury and its effect on antioxidant enzymes in brain, liver, and kidneys of mice. J Environ Sci Health B. 1999 Jul;34(4):645-60. doi: 10.1080/03601239909373219. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Ligand
- General Function
- Catalyzes the reduction of hydroperoxides in a glutathione-dependent manner thus regulating cellular redox homeostasis (PubMed:11115402, PubMed:36608588). Can reduce small soluble hydroperoxides such as H2O2, cumene hydroperoxide and tert-butyl hydroperoxide, as well as several fatty acid-derived hydroperoxides (PubMed:11115402, PubMed:36608588). In platelets catalyzes the reduction of 12-hydroperoxyeicosatetraenoic acid, the primary product of the arachidonate 12-lipoxygenase pathway (PubMed:11115402)
- Specific Function
- glutathione peroxidase activity
- Gene Name
- GPX1
- Uniprot ID
- P07203
- Uniprot Name
- Glutathione peroxidase 1
- Molecular Weight
- 22087.94 Da
References
- Hussain S, Atkinson A, Thompson SJ, Khan AT: Accumulation of mercury and its effect on antioxidant enzymes in brain, liver, and kidneys of mice. J Environ Sci Health B. 1999 Jul;34(4):645-60. doi: 10.1080/03601239909373219. [Article]
- Lubos E, Loscalzo J, Handy DE: Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011 Oct 1;15(7):1957-97. doi: 10.1089/ars.2010.3586. Epub 2011 Apr 10. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Inducer
- General Function
- Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems
- Specific Function
- DNA binding
- Gene Name
- SOD2
- Uniprot ID
- P04179
- Uniprot Name
- Superoxide dismutase [Mn], mitochondrial
- Molecular Weight
- 24750.015 Da
References
- Stephenson GA, Stowell JG, Toma PH, Pfeiffer RR, Byrn SR: Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. J Pharm Sci. 1997 Nov;86(11):1239-44. [Article]
Carriers
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc (PubMed:19021548). Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity). Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli (PubMed:6234017). Does not prevent iron uptake by the bacterial siderophore aerobactin (PubMed:6234017)
- Specific Function
- antioxidant activity
- Gene Name
- ALB
- Uniprot ID
- P02768
- Uniprot Name
- Albumin
- Molecular Weight
- 69365.94 Da
References
- Wu X, Liang H, O'Hara KA, Yalowich JC, Hasinoff BB: Thiol-modulated mechanisms of the cytotoxicity of thimerosal and inhibition of DNA topoisomerase II alpha. Chem Res Toxicol. 2008 Feb;21(2):483-93. doi: 10.1021/tx700341n. Epub 2008 Jan 16. [Article]
Transporters
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Inositol 1,4,5-trisphosphate-gated calcium channel that, upon inositol 1,4,5-trisphosphate binding, mediates calcium release from the endoplasmic reticulum (ER) (PubMed:10620513, PubMed:27108797). Undergoes conformational changes upon ligand binding, suggesting structural flexibility that allows the channel to switch from a closed state, capable of interacting with its ligands such as 1,4,5-trisphosphate and calcium, to an open state, capable of transferring calcium ions across the ER membrane (By similarity). Cytoplasmic calcium released from the ER triggers apoptosis by the activation of CAMK2 complex (By similarity). Involved in the regulation of epithelial secretion of electrolytes and fluid through the interaction with AHCYL1 (By similarity). Part of a complex composed of HSPA9, ITPR1 and VDAC1 that regulates mitochondrial calcium-dependent apoptosis by facilitating calcium transport from the ER lumen to the mitochondria intermembrane space thus providing calcium for the downstream calcium channel MCU that directly releases it into mitochondria matrix (By similarity). Regulates fertilization and egg activation by tuning the frequency and amplitude of calcium oscillations (By similarity)
- Specific Function
- ATP binding
- Gene Name
- ITPR1
- Uniprot ID
- Q14643
- Uniprot Name
- Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1
- Molecular Weight
- 313926.375 Da
Drug created at April 29, 2016 03:00 / Updated at July 03, 2024 00:10